JC, P., J, I., VJ, S., E, D., R, E., MI, T., . . . V, P. (2024). Anti-inflammatory therapy with nebulized dornase alfa for severe COVID-19 pneumonia: A randomized unblinded trial. ELife, 12, . https://doi.org/10.7554/eLife.87030
Chicago Style (17th ed.) CitationJC, Porter, et al. "Anti-inflammatory Therapy with Nebulized Dornase Alfa for Severe COVID-19 Pneumonia: A Randomized Unblinded Trial." ELife 12 (2024). https://doi.org/10.7554/eLife.87030.
MLA (9th ed.) CitationJC, Porter, et al. "Anti-inflammatory Therapy with Nebulized Dornase Alfa for Severe COVID-19 Pneumonia: A Randomized Unblinded Trial." ELife, vol. 12, 2024, https://doi.org/10.7554/eLife.87030.
Warning: These citations may not always be 100% accurate.
